✦ LIBER ✦

P-251 Randomized phase II trial of weekly carboplatin/paclitaxel (C/P) versus every-3-week C/P in advanced non-small cell lung cancer (NSCLC): A pure schedule trial

✍ Scribed by Socinski, Mark A.; Hensing, Thomas A.; Escudero, Miluska; Tynan, Maureen; Baggstrom, Maria; Ivanova, Anastasia; Li, J.H.; Bakri, Kamal

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

O-088 Phase III randomized trial compari

✍ Belani, C.; Ramalingam, S.; Perry, M.; LaRocca, R.; Rinaldi, D.; Gable, P.; Test 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 131 KB

Phase III trial of paclitaxel (P), carbo

✍ Socinski, MA; Sandler, AB; Petit, RG; Steagall, A; Hanover, CK; Natale, RB; Mill 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 212 KB

Phase II multicenter randomized trial of

✍ Belani, C.P; Barstis, J; Clark, R; Mills, G; Perry, M; Nattam, S 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 110 KB

P-22 Sequential chemotherapy of advanced

✍ Osterlind, Kell; Rytter, Carsten 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 193 KB

Preoperative treatment with paclitaxel a

✍ De Candis, D; Stani, S.C; Bidoli, P; Potepan, P; Bedini, V.A; Cataldo, I; Michet 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 108 KB

P-572 Phase I–II trial of TLK286 (telcyt

✍ Seguist, L.; Fidias, P.; Temel, J.; Kennedy, E.; Ostler, P.; Rabin, M.; Huberman 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 328 KB